Page last updated: 2024-11-07

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9576811
CHEMBL ID404482
SCHEMBL ID23531401
MeSH IDM0188120

Synonyms (36)

Synonym
n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime
d-gluconimidic acid, 2-(acetylamino)-2-deoxy-n-(((phenylamino)carbonyl)oxy)-, delta-lactone, (1z)-
pugnac
o-(2-acetamido-2-deoxyglucopyranosylidene)amino n-phenylcarbamate
(1z)-2-(acetylamino)-2-deoxy-n-(((phenylamino)carbonyl)oxy)-d-gluconimidic acid delta-lactone
nac-lapco
2CBJ
2VCB
CHEMBL404482
unii-awz7ve64b6
awz7ve64b6 ,
o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino n-phenylcarbamate
4AZ6
4AZG
4AZB
4AZI
(e)-o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino n-phenylcarbamate
2OXN
2VVS
3S6T
3OZP
pugnac, >=95% (hplc)
SCHEMBL23531401
n-[(2z,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(phenylcarbamoyl)oxy]imino}tetrahydro-2h-pyran-3-yl]acetamide (non-preferred name)
mfcd00145022
[(z)-[(3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] n-phenylcarbamate
d-gluconimidic acid, 2-(acetylamino)-2-deoxy-n-(((phenylamino)carbonyl)oxy)-, .delta.-lactone, (1z)-
n-((3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-(((phenylcarbamoyl)oxy)imino)tetrahydro-2h-pyran-3-yl)acetamide
a hexosaminidase a and b inhibitor
d-gluconimidic acid, 2-(acetylamino)-2-deoxy-n-[[(phenylamino)carbonyl]oxy]-, delta-lactone, (1z)-
HY-108241
bdbm50531967
CS-0027650
DTXSID101117756
AKOS040756644
EX-A7834
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (11)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HYALURONIDASEClostridium perfringensKi0.00540.00540.00540.0054AID977610
Chain A, Beta-hexosaminidaseVibrio choleraeKi0.03600.03600.03600.0360AID977610
Chain A, O-glcnacase Bt_4395Bacteroides thetaiotaomicron VPI-5482Ki0.04600.04600.04600.0460AID977610
Chain A, N-acetylglucosaminidaseOstrinia furnacalis (Asian corn borer)Ki0.14250.04500.14250.2400AID977610
Chain A, N-acetylglucosaminidaseOstrinia furnacalis (Asian corn borer)Ki0.14250.04500.14250.2400AID977610
Protein O-GlcNAcaseHomo sapiens (human)Ki0.05000.00040.08510.5400AID1780990
Protein O-GlcNAcaseRattus norvegicus (Norway rat)Ki0.05000.05000.05000.0500AID1624734
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Alpha-n-acetylglucosaminidaseClostridium perfringensKd5.50005.50005.50005.5000AID977611
Chain A, Alpha-n-acetylglucosaminidaseClostridium perfringensKd5.50005.50005.50005.5000AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-hexosaminidaseVibrio cholerae O1 biovar El Tor str. N16961Kinact0.04800.04800.04800.0480AID330954
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidaseHomo sapiens (human)Kinact0.04600.04600.04600.0460AID330955
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
N-acetylglucosamine metabolic processProtein O-GlcNAcaseHomo sapiens (human)
protein O-linked glycosylationProtein O-GlcNAcaseHomo sapiens (human)
glycoprotein catabolic processProtein O-GlcNAcaseHomo sapiens (human)
protein deglycosylationProtein O-GlcNAcaseHomo sapiens (human)
glycoprotein metabolic processProtein O-GlcNAcaseHomo sapiens (human)
carbohydrate metabolic processN-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidaseHomo sapiens (human)
protein glycosylationN-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidaseHomo sapiens (human)
protein targeting to lysosomeN-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidaseHomo sapiens (human)
lysosome organizationN-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidaseHomo sapiens (human)
protein modification processN-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidaseHomo sapiens (human)
secretion of lysosomal enzymesN-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
hyalurononglucosaminidase activityProtein O-GlcNAcaseHomo sapiens (human)
identical protein bindingProtein O-GlcNAcaseHomo sapiens (human)
[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activityProtein O-GlcNAcaseHomo sapiens (human)
beta-N-acetylglucosaminidase activityProtein O-GlcNAcaseHomo sapiens (human)
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activityN-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidaseHomo sapiens (human)
protein bindingN-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusProtein O-GlcNAcaseHomo sapiens (human)
cytosolProtein O-GlcNAcaseHomo sapiens (human)
membraneProtein O-GlcNAcaseHomo sapiens (human)
membraneN-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidaseHomo sapiens (human)
Golgi cisterna membraneN-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2008Proceedings of the National Academy of Sciences of the United States of America, May-06, Volume: 105, Issue:18
Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB.
AID1624734Inhibition of rat spleen OGA2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Ac
AID330955Inhibition of human family 84 O-GLcNAcase2007The Journal of biological chemistry, Jul-20, Volume: 282, Issue:29
Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance.
AID1369001Inhibition of recombinant human OGA expressed in Escherichia coli BL21(DE3) at 100 uM using 4-MU-GlcNAc as substrate measured after 30 mins by fluorescence assay relative to control2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
Selective inhibition of β-N-acetylhexosaminidases by thioglycosyl-naphthalimide hybrid molecules.
AID330958Ratio of human 84 O-GLcNAcase to Vibrio cholerae NagZ2007The Journal of biological chemistry, Jul-20, Volume: 282, Issue:29
Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance.
AID330954Inhibition of Vibrio cholerae NagZ2007The Journal of biological chemistry, Jul-20, Volume: 282, Issue:29
Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance.
AID1780990Inhibition of OGA (unknown origin) using pNP-O-GlcNAc as substrate assessed as inhibition constant incubated for 30 mins
AID330956Inhibition of human family 20 beta-hexosaminidase2007The Journal of biological chemistry, Jul-20, Volume: 282, Issue:29
Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance.
AID1780991Selectivity index, ratio of Ki for inhibition of HexB (unknown origin) to Ki for inhibition of OGA (unknown origin)
AID1624713Inhibition of OGA in mouse NIH/3T3 cells assessed as increase in O-GlcNAcylation at 20 uM after 24 hrs by Western blot analysis2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Ac
AID1369002Inhibition of Ostrinia furnacalis Hex1 expressed in Pichia pastoris at 100 uM using 4-MU-GlcNAc as substrate measured after 30 mins by fluorescence assay relative to control2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
Selective inhibition of β-N-acetylhexosaminidases by thioglycosyl-naphthalimide hybrid molecules.
AID1624735Inhibition of lysosomal hexosaminidase (unknown origin)2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Ac
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2006The EMBO journal, Apr-05, Volume: 25, Issue:7
Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.
AID1811Experimentally measured binding affinity data derived from PDB2006The EMBO journal, Apr-05, Volume: 25, Issue:7
Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2007The Journal of biological chemistry, Jul-20, Volume: 282, Issue:29
Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2013Organic & biomolecular chemistry, Dec-07, Volume: 11, Issue:45
Inhibition of the family 20 glycoside hydrolase catalytic modules in the Streptococcus pneumoniae exo-β-D-N-acetylglucosaminidase, StrH.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2011The Biochemical journal, Sep-15, Volume: 438, Issue:3
Active-pocket size differentiating insectile from bacterial chitinolytic β-N-acetyl-D-hexosaminidases.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2008The Journal of biological chemistry, Dec-12, Volume: 283, Issue:50
Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2013Organic & biomolecular chemistry, Dec-07, Volume: 11, Issue:45
Inhibition of the family 20 glycoside hydrolase catalytic modules in the Streptococcus pneumoniae exo-β-D-N-acetylglucosaminidase, StrH.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (87)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (4.60)18.2507
2000's36 (41.38)29.6817
2010's43 (49.43)24.3611
2020's4 (4.60)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other87 (98.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]